Targeted Therapies & Precision Oncology in Pancreatic Cancer Care
Breaking genetic codes to deliver tangible patient benefits. Dive into the evolution of pancreatic ductal adenocarcinoma (PDAC) treatment. Explore data on new KRAS inhibitors, clinical trials, and see how Zenovel's GCP services accelerate the transition from lab discovery to regulatory approval.